Models of hepatitis C suggest that screening groups that are at risk of contracting the disease could limit suffering and health care costs, scientists report. The research has found that targeting at-risk groups for screening could significantly reduce disease progression, which eventually necessitates a liver transplant. Researchers at the University of Cincinnati have found that… [Continue Reading]

Hepatitis C remains difficult to treat, and in patients that don’t improve with first-line treatments, doctors sometimes resort to a therapy called interferon monotherapy. According to a new study however, this treatment comes with significant side effects and does not improve patient outcomes. People with hepatitis C and chronic liver disease who relapsed or failed… [Continue Reading]

The treatment protocol for hepatitis C can be complex, and a new study shows that many patients have trouble taking their medications according to their doctor’s instructions. Some pills have to be taken every 8 hours, and researchers say that developing tools to help patients follow their treatment regimen could make a big difference in… [Continue Reading]

Hepatitis C is a virus of the liver that is spread by blood or body fluid contact, including shared needles, poorly screen blood transfusions, and sexual activity. The virus mutates so quickly, until now, it has been difficult to design an effective vaccine. Researchers have reported this week the development of an effective vaccine in… [Continue Reading]